サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1307229

免疫タンパク質市場：製品、用途、エンドユーザー別-2023-2030年の世界予測

Immunoprotein Market by Product, Application, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 191 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
免疫タンパク質市場：製品、用途、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 191 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

免疫タンパク質の世界市場は、2023年にCAGR 10.09%で196億4,000万米ドル、2030年には386億7,000万米ドルに達すると予測され、大きく成長すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の免疫タンパク質市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客ベース、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.免疫タンパク質の世界市場規模および予測は？

2.予測期間中、世界の免疫タンパク質市場を形成するCOVID-19の阻害要因と影響は？

3.免疫タンパク質の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.免疫タンパク質の世界市場における競争戦略は？

5.免疫タンパク質の世界市場における技術動向と規制の枠組みは？

6.免疫タンパク質の世界市場における主要ベンダーの市場シェアは？

7.免疫タンパク質の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 感染症および慢性疾患の発生率と有病率の増加
      • 世界中で高齢者人口が増加し、診断検査が増加
      • 迅速かつ正確な病気の診断を優先する
    • 抑制要因
      • 免疫タンパク質検査は日常的な微生物検査と比較してコストがかかる
    • 機会
      • 免疫診断機器の技術進歩
      • 重篤な疾患に対する治療法を発見するための効果的な研究開発の取り組み
    • 課題
      • 代替テストアプローチの利用可能性
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 免疫タンパク質市場：製品別

  • C3
  • C4
  • 遊離軽鎖
  • ハプトグロビン
  • IgA
  • 特異的IgE
  • 総IgE
  • IgG
  • IgM
  • 免疫固定
  • プレアルブミン
  • タンパク質電気泳動

第7章 免疫タンパク質市場：用途別

  • アレルギー検査
  • 自己免疫検査
  • 感染症検査
  • 腫瘍学および内分泌学検査

第8章 免疫タンパク質市場：エンドユーザー別

  • 病院とクリニック

第9章 南北アメリカの免疫タンパク質市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の免疫タンパク質市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの免疫タンパク質市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第13章 掲載企業一覧

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. IMMUNOPROTEIN MARKET RESEARCH PROCESS
  • FIGURE 2. IMMUNOPROTEIN MARKET SIZE, 2022 VS 2030
  • FIGURE 3. IMMUNOPROTEIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. IMMUNOPROTEIN MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 7. IMMUNOPROTEIN MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. IMMUNOPROTEIN MARKET DYNAMICS
  • FIGURE 9. IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. IMMUNOPROTEIN MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. IMMUNOPROTEIN MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. IMMUNOPROTEIN MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. IMMUNOPROTEIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. IMMUNOPROTEIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. IMMUNOPROTEIN MARKET SIZE, BY C3, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. IMMUNOPROTEIN MARKET SIZE, BY C4, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. IMMUNOPROTEIN MARKET SIZE, BY FREE LIGHT CHAINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. IMMUNOPROTEIN MARKET SIZE, BY HAPTOGLOBIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. IMMUNOPROTEIN MARKET SIZE, BY IGA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. IMMUNOPROTEIN MARKET SIZE, BY IGE SPECIFIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. IMMUNOPROTEIN MARKET SIZE, BY IGE TOTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. IMMUNOPROTEIN MARKET SIZE, BY IGG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. IMMUNOPROTEIN MARKET SIZE, BY IGM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. IMMUNOPROTEIN MARKET SIZE, BY IMMUNOFIXATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. IMMUNOPROTEIN MARKET SIZE, BY PREALBUMIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. IMMUNOPROTEIN MARKET SIZE, BY PROTEIN ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. IMMUNOPROTEIN MARKET SIZE, BY ALLERGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. IMMUNOPROTEIN MARKET SIZE, BY AUTOIMMUNE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. IMMUNOPROTEIN MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. IMMUNOPROTEIN MARKET SIZE, BY ONCOLOGY & ENDOCRINOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. IMMUNOPROTEIN MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. IMMUNOPROTEIN MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 152. IMMUNOPROTEIN MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 153. IMMUNOPROTEIN MARKET LICENSE & PRICING
目次
Product Code: MRR-43127F7279D4

The Global Immunoprotein Market is forecasted to grow significantly, with a projected USD 19.64 billion in 2023 at a CAGR of 10.09% and expected to reach a staggering USD 38.67 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Immunoprotein Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Immunoprotein Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM, Immunofixation, Prealbumin, and Protein Electrophoresis. The C3 is projected to witness significant market share during forecast period.

Based on Application, market is studied across Allergy Testing, Autoimmune Testing, Infectious Disease Testing, and Oncology & Endocrinology Testing. The Infectious Disease Testing is projected to witness significant market share during forecast period.

Based on End User, market is studied across Hospital & Clinics. The Hospital & Clinics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Immunoprotein Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Immunoprotein Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Immunoprotein Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Immunoprotein Market?

4. What is the competitive strategic window for opportunities in the Global Immunoprotein Market?

5. What are the technology trends and regulatory frameworks in the Global Immunoprotein Market?

6. What is the market share of the leading vendors in the Global Immunoprotein Market?

7. What modes and strategic moves are considered suitable for entering the Global Immunoprotein Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Immunoprotein Market, by Product, 2022 vs 2030
  • 4.3. Immunoprotein Market, by Application, 2022 vs 2030
  • 4.4. Immunoprotein Market, by End User, 2022 vs 2030
  • 4.5. Immunoprotein Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growth in incidence & prevalence of infectious and chronic diseases
      • 5.1.1.2. Rising geriatric population across world and increase in diagnostic tests
      • 5.1.1.3. Preferences for quick and accurate disease diagnosis
    • 5.1.2. Restraints
      • 5.1.2.1. Immunoprotein tests are costly as compared to routine microbiology assays
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in immunodiagnostic instruments
      • 5.1.3.2. Effective R&D efforts to discover therapeutics against critical disease
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative testing approaches
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Immunoprotein Market, by Product

  • 6.1. Introduction
  • 6.2. C3
  • 6.3. C4
  • 6.4. Free Light Chains
  • 6.5. Haptoglobin
  • 6.6. IgA
  • 6.7. IgE Specific
  • 6.8. IgE Total
  • 6.9. IgG
  • 6.10. IgM
  • 6.11. Immunofixation
  • 6.12. Prealbumin
  • 6.13. Protein Electrophoresis

7. Immunoprotein Market, by Application

  • 7.1. Introduction
  • 7.2. Allergy Testing
  • 7.3. Autoimmune Testing
  • 7.4. Infectious Disease Testing
  • 7.5. Oncology & Endocrinology Testing

8. Immunoprotein Market, by End User

  • 8.1. Introduction
  • 8.2. Hospital & Clinics

9. Americas Immunoprotein Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Immunoprotein Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Immunoprotein Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing